tiprankstipranks
Vericel Corporation (DE:ATQP)
NASDAQ:ATQP
Germany Market

Vericel (ATQP) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

ATQP Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Vericel
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ATQP Stock 12 Month Forecast

Average Price Target

€53.42
▲(88.11% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Vericel in the last 3 months. The average price target is €53.42 with a high forecast of €61.31 and a low forecast of €48.17. The average price target represents a 88.11% change from the last price of €28.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"25":"€25","62":"€62","34.25":"€34.3","43.5":"€43.5","52.75":"€52.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":61.3062793,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€61.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.42404339,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€53.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48.16921945,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€48.17</span>\n  </div></div>","useHTML":true}}],"tickPositions":[25,34.25,43.5,52.75,62],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.6,40.34663686923077,42.09327373846154,43.83991060769231,45.58654747692308,47.33318434615385,49.07982121538461,50.82645808461538,52.57309495384615,54.31973182307692,56.06636869230769,57.81300556153846,59.55964243076923,{"y":61.3062793,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.6,39.74031103,40.88062206,42.02093309,43.16124412,44.30155515,45.44186618,46.58217721,47.722488240000004,48.86279927,50.0031103,51.14342133,52.28373236,{"y":53.42404339,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.6,39.336093803846154,40.07218760769231,40.80828141153846,41.54437521538462,42.28046901923077,43.016562823076924,43.75265662692308,44.48875043076923,45.22484423461538,45.960938038461535,46.697031842307695,47.43312564615385,{"y":48.16921945,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.8,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.2,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.6,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€61.31Average Price Target€53.42Lowest Price Target€48.17
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:ATQP
Canaccord Genuity
Canaccord Genuity
€50.8
Buy
78.86%
Upside
Reiterated
06/24/26
Vericel Buy Rating Reiterated as New Burlington Facility Underpins Long-Term Growth; $58 Price Target Maintained
TD Cowen
€48.17
Buy
69.61%
Upside
Reiterated
06/10/26
Analysts Offer Insights on Healthcare Companies: Rezolute (NASDAQ: RZLT) and Vericel (NASDAQ: VCEL)
H.C. Wainwright Analyst forecast on DE:ATQP
H.C. Wainwright
H.C. Wainwright
€56.05€61.31
Buy
115.87%
Upside
Reiterated
05/08/26
Vericel price target raised to $70 from $64 at H.C. WainwrightVericel price target raised to $70 from $64 at H.C. Wainwright
Truist Financial Analyst forecast on DE:ATQP
Truist Financial
Truist Financial
Buy
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG
Hold
Reiterated
04/05/26
Hold Rating on Vericel: BARDA Contract Validates NexoBrid but Premium Valuation Limits Upside
Ladenburg Thalmann & Co. Analyst forecast on DE:ATQP
Unknown Analyst
Ladenburg Thalmann & Co.
Not Ranked
Ladenburg Thalmann & Co.
€54.3
Buy
91.20%
Upside
Reiterated
02/27/26
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)
Leerink Partners Analyst forecast on DE:ATQP
Leerink Partners
Leerink Partners
€43.79€42.04
Buy
48.02%
Upside
Reiterated
10/14/25
Leerink Partners Keeps Their Buy Rating on Vericel (VCEL)
Roth MKM Analyst forecast on DE:ATQP
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
Hold
Downgraded
09/17/25
Vericel (VCEL) was downgraded to a Hold Rating at Roth MKM
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:ATQP
Canaccord Genuity
Canaccord Genuity
€50.8
Buy
78.86%
Upside
Reiterated
06/24/26
Vericel Buy Rating Reiterated as New Burlington Facility Underpins Long-Term Growth; $58 Price Target Maintained
TD Cowen
€48.17
Buy
69.61%
Upside
Reiterated
06/10/26
Analysts Offer Insights on Healthcare Companies: Rezolute (NASDAQ: RZLT) and Vericel (NASDAQ: VCEL)
H.C. Wainwright Analyst forecast on DE:ATQP
H.C. Wainwright
H.C. Wainwright
€56.05€61.31
Buy
115.87%
Upside
Reiterated
05/08/26
Vericel price target raised to $70 from $64 at H.C. WainwrightVericel price target raised to $70 from $64 at H.C. Wainwright
Truist Financial Analyst forecast on DE:ATQP
Truist Financial
Truist Financial
Buy
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG
Hold
Reiterated
04/05/26
Hold Rating on Vericel: BARDA Contract Validates NexoBrid but Premium Valuation Limits Upside
Ladenburg Thalmann & Co. Analyst forecast on DE:ATQP
Unknown Analyst
Ladenburg Thalmann & Co.
Not Ranked
Ladenburg Thalmann & Co.
€54.3
Buy
91.20%
Upside
Reiterated
02/27/26
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)
Leerink Partners Analyst forecast on DE:ATQP
Leerink Partners
Leerink Partners
€43.79€42.04
Buy
48.02%
Upside
Reiterated
10/14/25
Leerink Partners Keeps Their Buy Rating on Vericel (VCEL)
Roth MKM Analyst forecast on DE:ATQP
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
Hold
Downgraded
09/17/25
Vericel (VCEL) was downgraded to a Hold Rating at Roth MKM
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ENOVEnovis
AXGNAxoGen
NGNENeurogene
ONCBeOne Medicines
OCGNOcugen
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Vericel

3 Months
Success Rate
8/17 ratings generated profit
47%
Average Return
+2.79%
Copying Josh Jennings's trades and holding each position for 3 Months would result in 47.06% of your transactions generating a profit, with an average return of +2.79% per trade.
1 Year
Success Rate
10/17 ratings generated profit
59%
Average Return
+7.68%
Copying Josh Jennings's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +7.68% per trade.
2 Years
Richard NewitterTruist Financial
Success Rate
11/15 ratings generated profit
73%
Average Return
+15.10%
Copying Richard Newitter's trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +15.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATQP Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
5
7
7
7
3
Buy
4
3
2
4
3
Hold
1
2
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
12
10
12
6
In the current month, ATQP has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ATQP average Analyst price target in the past 3 months is 53.42.
Each month's total comprises the sum of three months' worth of ratings.

ATQP Financial Forecast

ATQP Earnings Forecast

Next quarter’s earnings estimate for ATQP is -€0.03 with a range of -€0.05 to €0.00. The previous quarter’s EPS was -€0.10. ATQP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.
Next quarter’s earnings estimate for ATQP is -€0.03 with a range of -€0.05 to €0.00. The previous quarter’s EPS was -€0.10. ATQP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.

ATQP Sales Forecast

Next quarter’s sales forecast for ATQP is €63.58M with a range of €62.97M to €64.28M. The previous quarter’s sales results were €59.84M. ATQP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.
Next quarter’s sales forecast for ATQP is €63.58M with a range of €62.97M to €64.28M. The previous quarter’s sales results were €59.84M. ATQP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.

ATQP Stock Forecast FAQ

What is DE:ATQP’s average 12-month price target, according to analysts?
Based on analyst ratings, Vericel Corporation’s 12-month average price target is 53.42.
    What is DE:ATQP’s upside potential, based on the analysts’ average price target?
    Vericel Corporation has 88.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Vericel Corporation a Buy, Sell or Hold?
          Vericel Corporation has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Vericel Corporation’s share price target?
            The average share price target for Vericel Corporation is 53.42. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €61.31 ,and the lowest forecast is €48.17. The average share price target represents 88.11% Increase from the current price of €28.4.
              What do analysts say about Vericel Corporation?
              Vericel Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Vericel Corporation?
                To buy shares of DE:ATQP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.